TNF’s Merck MRK Stock Holding History

TNF’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$6.32M	Sell	59,724 -882	-1%	-$105K	2.28%	13
2024 Q2	$7.63M	Buy	60,606 +23,443	+63%	+$3.02M	2.81%	10
2024 Q1	$4.72M	Sell	37,163 -73	-0.2%	-$9K	1.87%	16
2023 Q4	$4.52M	Sell	37,236 -4,850	-12%	-$503K	1.79%	15
2023 Q3	$4.23M	Buy	42,086 +1,491	+4%	+$161K	1.96%	14
2023 Q2	$4.68M	Hold	40,595	–	–	2.04%	14
2023 Q1	$4.69M	Sell	40,595 -1,400	-3%	-$151K	2.11%	14
2022 Q4	$4.37M	Sell	41,995 -5,770	-12%	-$590K	1.99%	13
2022 Q3	$4.32M	Hold	47,765	–	–	2.21%	10
2022 Q2	$4.3M	Hold	47,765	–	–	2.05%	10
2022 Q1	$4.04M	Hold	47,765	–	–	1.82%	13
2021 Q4	$3.89M	Sell	47,765 -670	-1%	-$53.4K	1.63%	15
2021 Q3	$3.56M	Buy	+48,435	New	+$3.68M	1.53%	18

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TNF's MRK Position: Q3 2024 in Review

TNF reduced its Merck (MRK) stake by 1.5% in Q3 2024, selling an estimated $105K and leaving 59,724 shares worth $6.32M. The position accounts for 2.28% of the portfolio, ranked #13.

TNF first reported a position in MRK in Q3 2021 and has held it in 13 quarters since. The position peaked at $7.63M in Q2 2024. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

TNF held 59,724 shares of Merck worth $6.32M as of Q3 2024.
TNF sold 882 Merck shares in Q3 2024, an estimated $105K.
Merck made up 2.28% of TNF's portfolio in Q3 2024, its #13 holding.
TNF first reported a position in Merck in Q3 2021 and has held it in 13 quarters since.
TNF's Merck position peaked at $7.63M in Q2 2024.
3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on TNF's 13F filing for Q3 2024, filed 25 Oct 2024.